| EPE027 | Missed opportunities when we focus only on risk: Using value-added items to identify potential PrEP candidates | E-poster | Implementation science of scaling up prevention (including PrEP) |
| EPC197 | Missed opportunities for HIV testing and PrEP education in a high-risk population | E-poster | Scale up of PrEP |
| EPC409 | Missed opportunities for HIV testing among those tested for sexually transmitted infections: a systematic review and meta-analysis | E-poster | Integration of HIV testing with other services |
| EPC222 | Missed opportunities for HIV prevention and pre-exposure prophylaxis (PrEP) prescription at a safety-net health system in the Southern U.S | E-poster | Scale up of PrEP |
| EPA073 | MiRNAs as cardiovascular risk biomarkers in people living with HIV (PWH) | E-poster | HIV and co-morbidities |
| EPB241 | Minimal acquired resistance to dolutegravir and bictegravir in patients failing third-line ART in South Africa | E-poster | Resistance to ART |
| EPD305 | MINA. For Men. For Health ' applying private sector consumer marketing approaches to strengthen behaviour change communications for men living with HIV in South Africa | E-poster | Other behavioural approaches |
| EPA068 | Metformin acts on HIV reservoirs to facilitate their recognition by the immune system | E-poster | ARVs, small molecules and immunomodulating agents - pharmacodynamics and pharmacokinetics |
| OALBA0105 | Metabolomic and lipidomic correlates of time-to-HIV-rebound in viremic controllers treated with vesatolimod | Oral abstract session with live Q&A | Correlates of HIV susceptibility, and progression versus control (biomarkers and genetics) |
| EPA028 | Metabolic gene profiling of activated, terminally differentiated effector memory and exhausted CD8+ T cells in people living with HIV | E-poster | Cellular immunity; T cell vaccines |